Free Trial
ETR:SBS

Stratec (SBS) Stock Price, News & Analysis

Stratec logo
€26.65 -0.45 (-1.66%)
As of 05/27/2025

About Stratec Stock (ETR:SBS)

Key Stats

Today's Range
€26.60
€26.95
50-Day Range
€22.35
€28.40
52-Week Range
€36.00
€49.65
Volume
9,096 shs
Average Volume
6,253 shs
Market Capitalization
$320.17 million
P/E Ratio
31.98
Dividend Yield
2.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

SBS Stock News Headlines

Stratec SE (SBS.BE)
Man who predicted $100K Bitcoin sees a huge run coming for another coin …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
EQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR
Stratec Announces Changes to 2025 Financial Calendar
See More Headlines

SBS Stock Analysis - Frequently Asked Questions

Stratec's stock was trading at €29.80 at the beginning of the year. Since then, SBS shares have decreased by 10.6% and is now trading at €26.65.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Medical Devices
Sub-Industry
Utilities
Current Symbol
ETR:SBS
CIK
N/A
Fax
N/A
Employees
1,464
Year Founded
N/A

Profitability

Trailing P/E Ratio
32.52
Forward P/E Ratio
7.53
P/E Growth
10.43
Net Income
$9.89 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$247.60 million
Cash Flow
€1.14 per share
Price / Cash Flow
23.85
Book Value
€18.74 per share
Price / Book
1.45

Miscellaneous

Free Float
N/A
Market Cap
$325.57 million
Optionable
Not Optionable
Beta
0.16
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ETR:SBS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners